drugset / Trial / NCT01073059

Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal Subjects

NCT01073059

Phase 1 Completed 10 enrolled Chonbuk National University
RandomizedCrossoverOpen-labelHealth-services research

Summary

* This trial is conducted to assess pharmacokinetic characteristics of valproic acid when valproic acid single treatment and valproic acid \& ertapenem combination treatment * This trial is performed to evaluate safety of the combination treatment compare with single treatment * The investigators carry this trial out to study mechanism of combination treatment

Timeline

Start
2009-08
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ertapenem Small molecule
Subject Valproic Acid Small molecule

Indications

No indication recorded.